Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.
about
Chemotherapy versus best supportive care for extensive small cell lung cancerTreatment for small cell lung cancer, where are we now?-a reviewThe analysis, interpretation, and presentation of quality of life data.Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma.A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702A phase II study of carboplatin and prolonged administration of oral etoposide in patients with small-cell lung cancer.Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.Advances in systemic therapy of small cell cancer of the lung.Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.Chemotherapy for small cell lung cancer: a comprehensive reviewSmall cell lung cancer: treatment review.Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206Small cell oesophageal carcinoma: an institutional experience and review of the literature.Time and chemotherapy treatment trends in the treatment of elderly patients (age >/=70 years) with small cell lung cancer.Oral treatment with etoposide in small cell lung cancer - dilemmas and solutions.Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study.A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumoursSerum p53 antibodies: predictors of survival in small-cell lung cancer?Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients.Cisplatin plus etoposide versus other platin-based regimens for patients with extensive small-cell lung cancer: a systematic review and meta-analysis of randomised, controlled trials.Current challenges of lung cancer care in an aging population.Left behind? Drug discovery in extensive-stage small-cell lung cancer.An analysis of the outcomes of treatment of small cell lung cancer in the elderly.[A randomized controlled study of chemotherapy: etoposide combined with oxaliplatin or cisplatin regimens in the treatment of extensive-stage small cell lung cancer in elderly patients].Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
P2860
Q24240652-B66E83D1-B43F-47CA-B1C0-2C1043E9FEFAQ26767023-EF83402B-8A41-45D4-9D70-1E3C855630A1Q30913610-73F012F9-1DC9-4D60-9399-94E2C54745ACQ33338538-060C64C7-75D2-42D8-BF94-234E9E2501A2Q33344326-4EAE6A4C-CE8B-40A6-90B9-72BFA3ED53DDQ33375619-DE7544DA-5AB6-4C96-9745-8BF14D6C2E3AQ33501822-24E6C6E2-653D-4475-B0B4-6B174705C795Q33504834-473C5511-2BA8-4FCF-8B38-C7A61CBFB525Q34733937-2D60B16C-04C1-4039-B0A8-78E0C37C2D61Q34982142-9496F645-8A0B-43EB-BBBE-655E08C4A012Q35569379-4274A587-068A-45E8-8796-20B4C592CCC7Q36458604-26E8196E-7222-4B20-9DE1-2E4377F8FF3DQ36472573-1A855F8B-65AD-4C8A-AAC8-FFC073333720Q36610060-04103CB3-D236-4F37-942A-283C749C0CACQ36613507-D69CEFD8-3604-4120-A85B-00BB183972C3Q36613874-DA6AE041-B333-4FD1-B6D6-246823F59479Q36614590-14EA1AE6-1C27-4083-ACFE-E7DAF3920602Q36614847-D9C25600-A6EC-4C05-BBD3-07EADB420CCEQ36621503-A4F5A069-9A1F-46FC-AFEA-9957DDA9216DQ37117864-17CC779F-7CA8-479B-82E1-39BFB7FB88EDQ38005201-EC5AA973-A9FD-439E-9C88-1639F47A0F53Q38608627-7DD1C91B-7FC7-4505-9BF6-27D0D868B785Q39250401-56B2EC2E-131C-4C6B-98BF-364D37353CF8Q41465938-0B3E0FE5-7915-412C-AF2A-D6B067163E7BQ53124228-92A0CE2F-115E-4D3D-90D9-28725DBCFB46Q53598860-7C20BF1A-E4F5-4AF0-9911-0601DF49721E
P2860
Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Comparison of oral etoposide a ...... cil Lung Cancer Working Party.
@en
Comparison of oral etoposide a ...... cil Lung Cancer Working Party.
@nl
type
label
Comparison of oral etoposide a ...... cil Lung Cancer Working Party.
@en
Comparison of oral etoposide a ...... cil Lung Cancer Working Party.
@nl
prefLabel
Comparison of oral etoposide a ...... cil Lung Cancer Working Party.
@en
Comparison of oral etoposide a ...... cil Lung Cancer Working Party.
@nl
P1433
P1476
Comparison of oral etoposide a ...... cil Lung Cancer Working Party.
@en
P2093
D J Girling
P304
P356
10.1016/S0140-6736(96)02005-3
P407
P577
1996-08-01T00:00:00Z